デフォルト表紙
市場調査レポート
商品コード
1485767

ナノメディシン市場:モダリティ別、用途別、適応症別、分子タイプ別、国別、地域別-2024~2032年の産業分析、市場規模、市場シェア、予測

Nanomedicines Market, By Modality, By Application, By Indication, By Molecule Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 311 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
ナノメディシン市場:モダリティ別、用途別、適応症別、分子タイプ別、国別、地域別-2024~2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年04月13日
発行: AnalystView Market Insights
ページ情報: 英文 311 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ナノメディシン市場規模は2023年に2億3,104万米ドルとなり、2024~2032年にかけてCAGR 12.92%で拡大

ナノメディシン市場-市場力学

ドラッグデリバリーにおけるナノ技術の利用急増が市場需要を促進

ナノ技術を利用したドラッグデリバリーは、標的への送達、薬効の強化、副作用の軽減といった利点があることから、急速な成長を遂げています。この成長は、研究開発への投資の増加、ナノ材料とドラッグデリバリー技術の進歩、個別化医療と精密医療ソリューションへの需要の高まりによって後押しされています。さらに、COVID-19パンデミックは、ウイルスに対抗するためのナノメディシンベースのワクチンや治療の開発により、ドラッグデリバリーにおけるナノ技術の採用をさらに加速させています。

ナノメディシン市場-主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間(2024~2032年)に約12.92%のCAGRで毎年成長すると予測されています。

市場セグメンテーションでは、治療が2023年に最大の市場シェアを示すと予測されています。

用途別では、ドラッグデリバリーが2023年の主要タイプでした。

適応症別では、2023年に心血管が主要タイプでした。

地域別では、北米が2023年に収益を生み出す主要市場となっています。

ナノメディシン市場-セグメンテーション分析:

ナノメディシンの世界市場は、モダリティ、用途、適応症、分子タイプ、地域に基づいてセグメント化されます。

市場はモダリティに基づいて2つのカテゴリーに分けられます:治療では、特定の疾患や病状を対象に、治療目的でナノメディシンを使用します。診断では、病気や状態を診断するためにナノ技術を利用し、多くの場合、高度なイメージングや検出方法を用います。

市場は用途によって2つのカテゴリーに分けられます:ドラッグデリバリーは、標的薬剤送達、薬効の強化、副作用の最小化のためのナノメディカルの使用に焦点を当てています。IVDは、血液試験や遺伝子試験など、体外で行われる診断試験にナノ技術を利用します。インプラントは、生体適合性と性能を向上させるために、整形外科用インプラントや歯科用インプラントなどの医療用インプラントにナノ材料を使用します。

ナノメディシン市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。

北米と欧州は、先進的な研究インフラ、強固な規制の枠組み、ナノメディシンの研究開発への多額の投資を誇る主要参入企業です。一方、アジア太平洋は、医療支出の増加、慢性疾患の有病率の増加、革新的な治療法へのアクセスの拡大を背景に、大きな成長の可能性を示しています。ラテンアメリカと中東・アフリカ地域も、医療インフラ、価格、規制の複雑さに関する課題はあるもの、市場拡大の機会を提供しています。

ナノメディシン市場-競合情勢:

複数の主要企業が、研究開発投資、M&A、戦略的提携などの戦略を通じて市場を独占しています。Abbott Laboratories、Johnson & Johnson、Pfizerなどの企業は、ナノメディシン製品の多様なポートフォリオと広範な世界展開で市場をリードしています。さらに、Amgen、Gilead Sciences、Novartisといった革新的なバイオテクノロジー企業も、画期的な治療法や新薬候補で市場競争に貢献しています。競合が激化する中、各社は製品の革新、規制当局の承認、市場拡大の努力を通じて差別化に注力しています。

目次

第1章 ナノメディシン市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ナノメディシンの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ナノメディシン産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 ナノメディシン市場: COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 ナノメディシン市場情勢

  • ナノメディシン市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ナノメディシン市場-モダリティ別

  • 概要
    • モダリティ別セグメントシェア分析
    • 治療
    • 診断

第8章 ナノメディシン市場-用途別

  • 概要
    • 用途別セグメントシェア分析
    • ドラッグデリバリー
    • 体外診断
    • インプラント
    • ワクチン
    • その他

第9章 ナノメディシン市場-適応症別

  • 概要
    • 適応症別セグメントシェア分析
    • 腫瘍学
    • 感染症
    • 心臓血管
    • 神経学

第10章 ナノメディシン市場-分子タイプ別

  • 概要
    • 分子タイプ別セグメントシェア分析
    • ナノ粒子
    • ナノチューブ
    • ナノデバイス

第11章 ナノメディシン市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析-ナノメディシン業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Sanofi SA
    • Celgene Corporation
    • Nanobiotix
    • Luminex Corporation
    • Nanospectra Biosciences Inc
    • NanoCarrier Co. Ltd
    • Johnson &Johnson Services Inc
    • Merck &Co., Inc
    • Pfizer, Inc.
    • NanoCarrier Co. Ltd
    • Taiwan Liposome Company Ltd
    • Hoffmann-La Roche AG(Roche)
    • Gilead Science Inc
    • Ipsen SA.
    • その他

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nanomedicines Market: Modality Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Modality
  • TABLE Global Nanomedicines Market, by Modality 2019-2032 (USD Million)
  • TABLE Nanomedicines Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Nanomedicines Market, by Application 2019-2032 (USD Million)
  • TABLE Nanomedicines Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Nanomedicines Market, by Indication 2019-2032 (USD Million)
  • TABLE Nanomedicines Market: Molecule Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Molecule Type
  • TABLE Global Nanomedicines Market, by Molecule Type 2019-2032 (USD Million)
  • TABLE Nanomedicines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nanomedicines Market, by Region 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
目次
Product Code: ANV2665

REPORT HIGHLIGHT

Nanomedicines Market size was valued at USD 231.04 Million in 2023, expanding at a CAGR of 12.92% from 2024 to 2032.

The nanomedicine market encompasses the use of nanotechnology for diagnosing, treating, and preventing diseases at the molecular level, offering targeted delivery and enhanced efficacy in drug delivery and imaging applications. The development of personalized nanomedicines tailored to individual patient profiles, and increasing research focus on combination therapies and multifunctional nanoplatforms. However, restraints in the nanomedicine market include challenges related to regulatory approvals and safety concerns associated with nanomaterials. Opportunities abound in the integration of nanotechnology with other emerging technologies like artificial intelligence and gene editing for precision medicine approaches.

Nanomedicines Market- Market Dynamics

Rapidly increasing utilization of nanotechnology in drug delivery methods to propel market demand

The adoption of nanotechnology-based methods for drug delivery is experiencing rapid growth, driven by the advantages offered in terms of targeted delivery, enhanced drug efficacy, and reduced side effects. This growth is fueled by increasing investments in research and development, advancements in nanomaterials and drug delivery technologies, and a rising demand for personalized and precision medicine solutions. Additionally, the COVID-19 pandemic has further accelerated the adoption of nanotechnology in drug delivery, with the development of nanomedicine-based vaccines and therapeutics to combat the virus.

Nanomedicines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.92% over the forecast period (2024-2032)

Based on Modality segmentation, Treatment was predicted to show maximum market share in the year 2023

Based on application segmentation, Drug Delivery was the leading type in 2023

Based on Indication segmentation, Cardiovascular

was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Nanomedicines Market- Segmentation Analysis:

The Global Nanomedicines Market is segmented on the basis of Modality, Application, Indication, Molecule Type, and Region.

The market is divided into two categories based on Modality: Treatment involves the use of nanomedicines for therapeutic purposes, targeting specific diseases or medical conditions. Diagnostics utilizes nanotechnology for diagnosing diseases or conditions, often through advanced imaging or detection methods.

The market is divided into two categories based on application: Drug Delivery focuses on the use of nanomedicines for targeted drug delivery, enhancing drug efficacy, and minimizing side effects. IVD utilizes nanotechnology for diagnostic tests performed outside the body, such as blood tests or genetic testing. An implant involves the use of nanomaterials in medical implants, such as orthopedic implants or dental implants, to improve biocompatibility and performance.

Nanomedicines Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America and Europe stand as key players, boasting advanced research infrastructure, robust regulatory frameworks, and significant investments in nanomedicine research and development. Meanwhile, the Asia-Pacific region demonstrates significant growth potential, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and expanding access to innovative therapies. Latin America and the Middle East & Africa regions also present opportunities for market expansion, albeit with challenges related to healthcare infrastructure, affordability, and regulatory complexities.

Nanomedicines Market- Competitive Landscape:

Several key players are dominaning the market through strategies such as research and development investments, mergers and acquisitions, and strategic partnerships. Companies like Abbott Laboratories, Johnson & Johnson, and Pfizer lead the market with diverse portfolios of nanomedicine products and extensive global reach. Additionally, innovative biotechnology firms such as Amgen, Gilead Sciences, and Novartis contribute to market competitiveness with groundbreaking therapies and novel drug candidates. As competition intensifies, companies focus on differentiation through product innovation, regulatory approvals, and market expansion efforts.

Recent Developments:

In January 2022, Pfizer Inc. and Acuitas Therapeutics disclosed a development and option agreement, wherein Pfizer will hold the opportunity to license Acuitas' LNP technology for potential utilization in up to ten targets for vaccine or therapeutic development on a non-exclusive basis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOMEDICINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Sanofi SA

Celgene Corporation

Nanobiotix

Luminex Corporation

Nanospectra Biosciences Inc

NanoCarrier Co. Ltd

Johnson & Johnson Services Inc

Merck & Co., Inc

Pfizer, Inc.

NanoCarrier Co. Ltd

Taiwan Liposome Company Ltd

Hoffmann-La Roche AG (Roche)

Gilead Science Inc

Ipsen SA.

Others

GLOBAL NANOMEDICINES MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Treatment
  • Diagnostics

GLOBAL NANOMEDICINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Delivery
  • IVD
  • Implant
  • Vaccine
  • Others

GLOBAL NANOMEDICINES MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Infectious
  • Cardiovascular
  • Neurological

GLOBAL NANOMEDICINES MARKET, BY MOLECULE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Nanoparticle
  • Nanotube
  • Nanodevice

GLOBAL NANOMEDICINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Nanomedicines Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Nanomedicines Market Snippet by Modality
    • 2.1.2.Nanomedicines Market Snippet by Application
    • 2.1.3.Nanomedicines Market Snippet by Indication
    • 2.1.4.Nanomedicines Market Snippet by Molecule Type
    • 2.1.5.Nanomedicines Market Snippet by Country
    • 2.1.6.Nanomedicines Market Snippet by Region
  • 2.2.Competitive Insights

3.Nanomedicines Key Market Trends

  • 3.1.Nanomedicines Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Nanomedicines Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Nanomedicines Market Opportunities
  • 3.4.Nanomedicines Market Future Trends

4.Nanomedicines Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Nanomedicines Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Nanomedicines Market Landscape

  • 6.1.Nanomedicines Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Nanomedicines Market - By Modality

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Modality, 2023 & 2032 (%)
    • 7.1.2.Treatment
    • 7.1.3.Diagnostics

8.Nanomedicines Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Drug Delivery
    • 8.1.3.IVD
    • 8.1.4.Implant
    • 8.1.5.Vaccine
    • 8.1.6.Others

9.Nanomedicines Market - By Indication

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2.Oncology
    • 9.1.3.Infectious
    • 9.1.4.Cardiovascular
    • 9.1.5.Neurological

10.Nanomedicines Market - By Molecule Type

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2.Nanoparticle
    • 10.1.3.Nanotube
    • 10.1.4.Nanodevice

11.Nanomedicines Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Nanomedicines Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Nanomedicines Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Nanomedicines Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Nanomedicines Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Nanomedicines Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Nanomedicines Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Sanofi SA
    • 12.2.2.Celgene Corporation
    • 12.2.3.Nanobiotix
    • 12.2.4.Luminex Corporation
    • 12.2.5.Nanospectra Biosciences Inc
    • 12.2.6.NanoCarrier Co. Ltd
    • 12.2.7.Johnson & Johnson Services Inc
    • 12.2.8.Merck & Co., Inc
    • 12.2.9.Pfizer, Inc.
    • 12.2.10.NanoCarrier Co. Ltd
    • 12.2.11.Taiwan Liposome Company Ltd
    • 12.2.12.Hoffmann-La Roche AG (Roche)
    • 12.2.13.Gilead Science Inc
    • 12.2.14.Ipsen SA.
    • 12.2.15.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us